A genomic classification model enables risk stratification of paediatric endemic Burkitt lymphoma

Peixun Zhou, Amir Enshaei, Alexander Newman, Kondwani Banda, George Chagaluka, Irvin Lampert, Susan Van Noorden, Amy Erhorn, Amy Barnard, Rachel Crossland, Sarah Wilkinson, Sirintra Nakjang, Anthony V Moorman, Katrina Wood, Despina Televantou, Peter Carey, Simon Bomken, Chris M. Bacon, Simon Bailey, Elizabeth MolyneuxVikki Rand

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Burkitt lymphoma (BL) is the most common childhood cancer in sub‐Saharan Africa. Despite excellent outcomes in high‐income settings, the delivery of intensive multi‐agent chemo‐immunotherapy is prevented in low‐income countries by high costs and insufficient supportive care facilities. Consequently, patient outcome remains unsatisfactory and new therapeutic approaches are urgently needed to improve survival
Original languageEnglish
Pages (from-to)51-51
JournalBritish Journal of Haematology
Volume182
Issue numbers1
DOIs
Publication statusPublished - 19 Sep 2018
EventSixth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma - Rotterdam, Netherlands
Duration: 26 Sep 201829 Sep 2018
https://onlinelibrary.wiley.com/toc/13652141/2018/182/S1

Fingerprint Dive into the research topics of 'A genomic classification model enables risk stratification of paediatric endemic Burkitt lymphoma'. Together they form a unique fingerprint.

Cite this